Emergent wins FDA all-clear to restart J&J COVID-19 vaccine production in Baltimore

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 30, 2021 at 11:32 AM.

  1. #1 cafead, Jul 30, 2021 at 11:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,039
    Likes Received:
    3
    via Some three months after federal officials called for a manufacturing pause, Emergent BioSolutions has righted the ship at its beleaguered Bayview facility.

    Emergent won the FDA’s blessing to restart production of Johnson & Johnson’s COVID-19 vaccine at its Baltimore, Maryland, plant, the company said Thursday. The move follows “extensive” FDA reviews, plus “close coordination” with the agency and J&J on the quality enhancement plan Emergent debuted in May.

    article source
     
    Quote

Reply to Thread